Artificial Intelligence in Depression - Medication Enhancement

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Depression
Interventions
DEVICE

Clinical Decision Support System

Clinical Decision Support System using Measurement-Based Care and Digital Decision Support Platform

Trial Locations (11)

24153

Salem VAMC, Salem

30322

Emory University, Atlanta

33125

South Florida Veterans Affairs, Miami

48109

University of Michigan, Michigan Medicine, Ann Arbor

06516

VA New Haven, VA Connecticut Healthcare System, West Haven

M6J1H4

CAMH: The Centre for Addiction and Mental Health, Toronto

H1N3V2

CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal

H3T1E2

CIUSSS De Centre Ouest De L'île de Montréal, Montreal

H4A3J1

McGill University Health Care Centre (MUHC), Montreal

H4H1R3

CIUSSS De L'Ouest de L'île de Montréal, Montreal

H4H 1R3

Douglas Mental Health University Institute, Verdun

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

McGill University

OTHER

lead

Aifred Health

INDUSTRY

NCT04655924 - Artificial Intelligence in Depression - Medication Enhancement | Biotech Hunter | Biotech Hunter